Skip to main content
. 2013 Jul 5;14:136. doi: 10.1186/1471-2369-14-136

Figure 2.

Figure 2

Mean changes of SCr (2A) and eGFR (2B) at day 1 (D1), day 2 (D2), and day 3 (D3) after operation compared with baseline in patients randomized to placebo (black line) or rHuEPO (gray line). *p < 0.05 compared between the placebo and rHuEPO group.